Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Gynecologic Oncology|December 13, 2002
A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patientsH Homesley, B Benigno, J Williams, et al.Investigational New Drugs|January 1, 1983
Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group studyJ C Arseneau, B Bundy, H Homesley, et al.American Journal of Clinical Oncology|August 1, 1983
Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology GroupJ T Thigpen, L Lagasse, H Homesley, et al.Cancer|August 15, 1981
Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology GroupT Thigpen, H Shingleton, H Homesley, et al.Cancer Treatment Reports|September 1, 1979
cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology GroupT Thigpen, H Shingleton, H Homesley, et al.Clinical Pharmacology and Therapeutics|April 1, 1988
Rescue factor: a design for evaluating long-acting analgesicsJ J Savarese, G B Thomas, H Homesley, et al.Seminars in Oncology|December 1, 1992
Gynecologic Oncology Group studies with ifosfamideG P Sutton, J A Blessing, A Manetta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, J Beecham, et al.American Journal of Clinical Oncology|February 1, 1982
Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervixJ C Arseneau, B Bundy, T Dolan, et al.American Journal of Clinical Oncology|February 1, 1986
Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group StudyC P Morrow, B N Bundy, J Hoffman, et al.Pageof 2